Navigation Links
Two NYU Scientists Named Howard Hughes Medical Institute's early career scientists
Date:3/26/2009

Two researchers from NYU School of Medicine have been named Early Career Scientists by the Howard Hughes Medical Institute (HHMI). The honorees, Iannis Aifantis, Ph.D. associate professor of pathology, co-director of the Cancer Stem Cell Program at the NYU Cancer Institute and Jeremy S. Dasen Ph.D., assistant professor of physiology and neuroscience at NYU School of Medicine are among 50 of the nation's top scientists being honored by HHMI under this new initiative to establish, develop and grow unique research programs.

Dr. Aifantis, a cancer biologist investigating T-cell acute lymphocytic leukemia, a common form of leukemia in children and Dr. Dasen, a neuroscientist investigating the molecular code that helps developing motor neurons in the spinal cord connect with the muscles they control, will both receive a six-year appointment to the HHMI and funding to further explore their areas of research. HHMI will provide each NYU researcher with his full salary, benefits, and a research budget of $1.5 million over six-years.

"The entire NYU Langone Medical Center community is proud of the groundbreaking work being conducted by Dr. Aifantis and Dr. Dasen and we congratulate them on their selection as HHMI Early Career Scientists," said Robert I. Grossman, M.D., Dean and CEO of NYU Langone Medical Center. "These awards are recognition of the immense talent of these two scientists and the importance of the work that they are pursuing."

Dr. Aifantis has made majors strides towards understanding and developing new treatments for T-cell acute lymphocytic leukemia. He recently discovered a molecular door by which T cells, the soldiers of the immune system, slip into spinal fluid and the brain after they become malignant. Blocking this process could save thousands of lives each year. Aifantis is now testing hundreds of potential drugs that might prevent malignant T cells from reaching the nervous system. At the same time, he is learning what goes awry in blood stem cells that transform into leukemic T cells. Such insights may provide even more ways to combat deadly blood cancers.

Dr. Dasen's research focuses on deciphering the molecular code that helps developing motor neurons in the spinal cord connect with the muscles they control. Understanding this code, which relies on a large family of genes that produce proteins called Hox factors, may help scientists restore motor neuron function in people whose spinal cords have been damaged by trauma or disease. Dasen, has found that Hox proteins are not just present in motor neurons; they are pervasive throughout the nervous system. He plans to explore whether Hox proteins in interneurons and sensory neurons, which control motor neuron firing patterns and transmit feedback about muscle action, help assemble the complete circuits that control walking and running.

"Dr. Aifantis and Dr. Dasen are fantastically promising scientists and scholars whom we are so proud and please to have as colleagues," said Vivian S. Lee, M.D., Ph.D., M.B.A., vice dean for science and chief scientific officer & senior vice president at NYU Langone Medical Center. "The recognition of their transformative research at NYU is another example of our world renowned medical institution's talented researchers being acknowledged for making strides towards finding treatments and future cures for disease."

Early Career Scientist Selection Process

NYU School of Medicine's Early Career Scientists Dr. Aifantis and Dr. Dasen are among researchers at 33 institutions across the United States, who have led their own laboratories for two to six years making considerable contributions to biomedical research. The idea of this new initiative started in 2007, when HHMI began to look for opportunities to diversify its research portfolio. The Institute decided to establish a new research program to provide much-needed support to some of the nation's best early career faculty at a time when they most need the help.

In March 2008, HHMI unveiled its new Early Career Scientist program and announced a nationwide competition seeking applications from the nation's best early career scientists. Those working in all areas of basic biological and biomedical research and areas of chemistry, physics, computer science, and engineering that are directly related to biology or medicine were invited to apply. The competition drew more than 2,000 applicants. In selecting the finalists, HHMI was guided by the same "people, not projects" philosophy that defines its investigator program. Like HHMI investigators, the Early Career Scientists will have the freedom to explore and, if necessary, change direction in their research. The 41 men and 9 women will begin their six-year, nonrenewable appointments to HHMI in September 2009. The Institute anticipates a second Early Career Scientist competition in 2012.


'/>"/>

Contact: Lauren Woods
lauren.woods@nyumc.org
212-404-3555
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related medicine news :

1. Three Johns Hopkins researchers named Howard Hughes Medical Institute early career scientists
2. Wayne State University Scientists ID New Biomarker for Prostate Cancer
3. URI scientists reveal mechanism that regulates cancer-causing gene
4. Scientists ID New Biomarker for Prostate Cancer
5. Herpes: Scientists find cellular process that fights virus
6. New book chronicles the journeys of women physicians and scientists to fighting cancer
7. University of Washington scientists one step closer to stopping bone loss during spaceflight
8. New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer
9. Biotech company cofounded by BIDMC scientists targets natural killer T-cells
10. Scientists trial device to treat chemotherapy-related nausea
11. Scientists closer to understanding how to control high blood sugar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
(Date:9/12/2017)... SAN FRANCISCO , Sept. 12, 2017 /PRNewswire/ ... Lifecycle Management Solutions (VLMS), is pleased to announce ... as a member of its Board of Directors ... 2017. ValGenesis VLMS enables life science companies to ... eliminate the use of paper in this process. ...
Breaking Medicine Technology: